Skip to main content
OpenTrials

Clinical trial condition

Systemic Sclerosis

Explore clinical trials studying Systemic Sclerosis. Study availability and eligibility vary by location and protocol.

223 public trials 51 recruiting studies
Refine in advanced search Browse all conditions

Systemic Sclerosis trial results

Recruiting

A Study of AZD0120 in Autoimmune Diseases

NCT07295847

Conditions
Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases, +15 more
Locations
  • Research Site Tucson, Arizona, United States
  • Research Site Stanford, California, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Ann Arbor, Michigan, United States
View all 22 locations
View Trial Details
Recruiting

A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease

NCT07085104

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Dermatomyositis, +24 more
Locations
  • Mayo Clinic Phoenix, Arizona, United States
  • Loma Linda University Medical Center Loma Linda, California, United States
  • University of Colorado Denver Aurora, Colorado, United States
  • Mayo Clinic Jacksonville, Florida, United States
View all 14 locations
View Trial Details
Recruiting

A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease

NCT06925542

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Diffuse Cutaneous Systemic Sclerosis, +23 more
Locations
  • Stanford University Medical Center Redwood City, California, United States
  • Northwestern Medicine, Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States
  • University of Iowa Iowa City, Iowa, United States
  • Manning Family Children's Hospital of New Orleans New Orleans, Louisiana, United States
View all 14 locations
View Trial Details
Recruiting

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

NCT06328777

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +6 more
Locations
  • Yale University New Haven, Connecticut, United States
  • Mayo Clinic Florida Jacksonville, Florida, United States
  • Northwestern Memorial Hospital Chicago, Illinois, United States
  • The University of Chicago Medical Center Chicago, Illinois, United States
View Trial Details
Recruiting

Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk

NCT05098704

Conditions
Connective Tissue Diseases, Scleroderma, Scleroderma, Diffuse, +4 more
Locations
  • CH de la Cote Basque - service de rhumatologie Bayonne, France
  • CHU de Bordeaux - service de Médecine Interne et Maladies Infectieuses Bordeaux, France
  • CHU de Bordeaux - service de rhumatologie Bordeaux, France
  • CHU de Brest - service de rhumatologie Brest, France
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis

NCT07335562

Conditions
Connective Tissue Diseases, Scleroderma, Systemic, Skin Diseases, +2 more
Locations
  • Local Institution - 0035 Scottsdale, Arizona, United States
  • University of Colorado Anschutz Medical Campus Aurora, Colorado, United States
  • Local Institution - 0001 Denver, Colorado, United States
  • Local Institution - 0069 Miami, Florida, United States
View all 56 locations
View Trial Details

Related conditions